KLP Kapitalforvaltning’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$292M Buy
317,879
+9,600
+3% +$9.73M 1.15% 12
2025
Q4
$331M Buy
308,279
+3,560
+1% +$3.4M 1.28% 11
2025
Q3
$233M Buy
304,719
+700
+0.2% +$521K 0.92% 13
2025
Q2
$237M Buy
304,019
+10,000
+3% +$7.77M 1.02% 14
2025
Q1
$243M Buy
294,019
+5,100
+2% +$4.24M 1.19% 13
2024
Q4
$223M Buy
+288,919
New +$239M 1.06% 11

Other funds holding LLY

KLP Kapitalforvaltning's LLY Position: Q1 2026 in Review

KLP Kapitalforvaltning increased its Eli Lilly (LLY) stake by 3.1% in Q1 2026, buying an estimated $9.73M and bringing the position to 317,879 shares worth $292M. The position accounts for 1.15% of the portfolio, ranked #12.

KLP Kapitalforvaltning first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $331M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • KLP Kapitalforvaltning held 317,879 shares of Eli Lilly worth $292M as of Q1 2026.
  • KLP Kapitalforvaltning bought 9,600 Eli Lilly shares in Q1 2026, an estimated $9.73M.
  • Eli Lilly made up 1.15% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #12 holding.
  • KLP Kapitalforvaltning first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • KLP Kapitalforvaltning's Eli Lilly position peaked at $331M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.